Organoids Forecast Chemotherapy, PARP Inhibitor Outcomes in Ovarian Cancer
In a groundbreaking study that could reshape the treatment landscape for advanced ovarian cancer, researchers have successfully utilized patient-derived organoids as a predictive tool for...
















